Media advisory--Cancer patients treated in world-first clinical trial of Canadian viral therapy

July 8, 2015

Ottawa – Media are invited to The Ottawa Hospital on Friday, July 10th, 2015, to meet one of the first patients treated in a world-first clinical trial of a Canadian viral therapy. Researchers who discovered and are developing and testing the therapy will be present, along with representatives of supporting organizations.

• Friday, July 10, 2015, 9:30 a.m. to 11:00 a.m.

• The Ottawa Hospital, General Campus, 501 Smyth Road, Ottawa, ON
o Media tour — Cancer Centre entrance at 9:30 a.m.
o News conference — Critical Care Wing Atrium (main floor) at 10:00 a.m. (scientists available for interviews following news conference)

• Mr. John Fraser, MPP Ottawa South
• Dr. John Bell (The Ottawa Hospital, University of Ottawa)
• Dr. Brian Lichty (McMaster University)
• Dr. David Stojdl (Children’s Hospital of Eastern Ontario, University of Ottawa)
• Dr. Janet Dancey (NCIC Clinical Trials Group)
• Dr. Derek Jonker (The Ottawa Hospital, University of Ottawa)
• Patient (may only be available during the news conference)

• Map:
• Photos and graphics:

• The Ottawa Hospital: Jenn Ganton, 613-614-5253,

• McMaster University: Susan Emigh, 905-525-9140, ext. 22555,

• Children’s Hospital of Eastern Ontario: Adrienne Vienneau, 613-513-8437,

• Ontario Institute for Cancer Research: Christopher Needles, 416-673-8505,

• NCIC Clinical Trials Group: Heather Stanton, 613-533-6430,